Karin Jooss - 07 Jan 2021 Form 4 Insider Report for Gritstone bio, Inc.

Role
Executive Vice President and Chief Scientific Officer
Signature
/s/ Rahsaan Thompson, Attorney-in-Fact for Karin Jooss
Issuer symbol
N/A
Transactions as of
07 Jan 2021
Net transactions value
$0
Form type
4
Filing time
19 Nov 2021, 16:20:21 UTC
Next filing
04 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRTS Common Stock Award $0 +27,900 +8.7% $0.000000 349,784 07 Jan 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") which vest in two equal annual installments over a two year period measured from the grant date. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
F2 Includes 27,900 RSUs which are subject to vesting.

Remarks:

Executive Vice President and Chief Scientific Officer